Advanced glycation end-products induce apoptosis of bovine retinal pericytes in culture: Involvement of diacylglycerol/ceramide production and oxidative stress induction

Free Radical Biology and Medicine

Volumn 33, Issue 2, 2002, Pages 236-247

  Denis, Ulriche ^a   Lecomte, Marc ^a   Paget, Clarisse ^a   Ruggiero, Daniel ^a   Wiernsperger, Nicolas ^a   Lagarde, Michel ^a  

^a INSERM   (France)

Author keywords

Advanced glycation end products; Apoptosis; Ceramides; Diabetic retinopathy; Free radicals; Oxidative stress; Pericyte

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANTIOXIDANT; BOVINE SERUM ALBUMIN; CERAMIDE; CHELATING AGENT; DESIPRAMINE; DIACYLGLYCEROL; ENZYME INHIBITOR; METHYLGLYOXAL; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELIN PHOSPHODIESTERASE INHIBITOR; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE; UNCLASSIFIED DRUG; 1,2-DIACYLGLYCEROL; ADRENERGIC RECEPTOR AFFECTING AGENT; ADVANCED GLYCATION END PRODUCTS BOVINE SERUM ALBUMIN; ADVANCED GLYCATION END PRODUCTS-BOVINE SERUM ALBUMIN; ANTINEOPLASTIC AGENT; ASCORBIC ACID; BRIDGED COMPOUND; CHELEX 100; MESSENGER RNA; PENTETIC ACID; RESIN; THIOKETONE; TRICYCLODECANE 9 YL XANTHOGENATE; TRICYCLODECANE-9-YL-XANTHOGENATE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CATTLE; CELL CULTURE; CELL LEVEL; CELL LOSS; CELL PROTECTION; CHEMICAL BINDING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENZYME ACTIVATION; NONHUMAN; OXIDATIVE STRESS; PERICYTE; PRIORITY JOURNAL; RETINA CELL; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PATHOLOGY; RETINA;

ADRENERGIC UPTAKE INHIBITORS; ANIMAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; ASCORBIC ACID; BRIDGED COMPOUNDS; CATTLE; CELLS, CULTURED; CERAMIDES; CHELATING AGENTS; DESIPRAMINE; DIGLYCERIDES; GLYCOSYLATION END PRODUCTS, ADVANCED; OXIDATIVE STRESS; PENTETIC ACID; PERICYTES; PHOSPHOLIPASE C; RETINA; RNA, MESSENGER; SERUM ALBUMIN, BOVINE; SPHINGOMYELIN PHOSPHODIESTERASE; THIONES; ANIMALS; RESINS, SYNTHETIC;

BOVINAE;

EID: 0037098871     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)00879-1     Document Type: Article

References (57)

1. Retinal vascular patterns VI. Mural cells of the retinal capillaries
2. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy
3. Altered mRNA levels of antioxidant enzymes in pre-apoptotic pericytes from human diabetic retinas
4. Bax is increased in the retina of diabetic subjects and in associated with pericyte apoptosis in vivo and in vitro
5. The Amadori product on protein: Structure and reactions
6. The pathological implications of protein glycation
7. The formation of methylglyoxal from triose phosphate. Investigation using a specific assay for methylglyoxal
8. Identification of ethanol-inducible P-450 isozyme 3α as the acetone and acetol monooxygenase of rabbit microsomes
9. Metformin reduce systemic methylglyoxal levels in type 2 diabetes
10. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications
11. Protein modification by methylglyoxal: Chemical nature and synthetic mechanism of a major fluorescent adduct
12. Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin
13. N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins
14. Protein cross-linking by the Maillard reaction. Isolation, characterization, and in vivo detection of a lysine-lysine cross-link derived from methylglyoxal
15. Chemical modification of proteins by methylglyoxal
16. Amadori albumin in type 1 diabetic patients: Correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries
17. Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and AGE-infused rats
18. Advanced glycation end products and their receptors co-localize in rat organs susceptible to diabetic microvascular injury
19. Receptor mediated toxicity to pericytes of advanced glycosylation end products: A possible mechanism of pericyte loss in diabetic microangiopathy
20. Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: Relevance to diabetic retinopathy
21. Growth modulation of retinal microvascular cells by early and advanced glycation products
22. Altered proliferation of retinal microvascular cells on glycated matrix
23. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy
24. Receptor-mediated endocytic uptake of methylglyoxal-modified serum albumin. Competition with advanced glycation end product-modified serum albumin at the advanced glycation end product receptor
25. Effect of advanced glycation end products on oxidative stress in endothelial cells in culture: A warning on the use of cells studied in serum-free media
26. Transition metals bind to glycated proteins forming redox active "glycochelates": Implications for the pathogenesis of certain diabetic complications
27. In the absence of catalytic metals ascorbate does not autoxidize at pH 7: Ascorbate as a test for catalytic metals
28. The role of metal-catalyzed oxidation in the formation of advanced glycation end-products: An in vitro study on collagen
29. Docosahexaenoic acid is a major n-3 polyunsaturated fatty acid in bovine retinal microvessels
30. Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells
31. A rapid method of total lipid extraction and purification
32. A rapid, sensitive and specific method for the determination of protein in dilute solution
33. Immunological evidence for methylglyoxal-derived modifications in vivo. Determination of antigenic epitopes
34. Growth of bovine retinal pericytes and endothelial cells in high hexose concentrations
35. Regulation of ceramide production and apoptosis
36. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling
37. CD95-mediated apoptosis in vivo involves acid sphingomyelinase
38. Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance
39. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium monoliforme
40. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown
41. Caspase-dependent ceramide production in Fas- and HLA class I-mediated peripheral T cell apoptosis
42. Interruption of TPA-induced signals by an antiviral and antitumoral xanthate compound: Inhibition of a phospholipase C-type reaction
43. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy
44. Pharmacological inhibition of diabetic retinopathy: Aminoguanidine and aspirin
45. Early cellular and molecular changes induced by diabetes in the retina
46. Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor
47. Modification of enzymatic antioxidants in retinal microvascular cells by glucose or advanced glycation end products
48. Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover
49. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation
50. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death
51. Rapid and specific reactive oxygen species generation via NADPH oxidase activation during Fas-mediated apoptosis
52. Involvement of oxidants and oxidant-generating enzyme(s) in tumour-necrosis-factor-alpha-mediated apoptosis: Role for lipoxygenase pathway but not mitochondrial respiratory chain
53. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins
54. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE
55. Prevention of pericyte loss by trolox in diabetic rat retina
56. Protein aging by carboxymethylation of lysines generates sites for divalent metal and redox active copper binding: Relevance to diseases of glycoxidative stress
57. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy